Home › Asset managers › UBS › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal UBS voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,366 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | UBS voted | Funds |
|---|---|---|---|---|---|---|---|
| American Woodmark Corporation | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Ameris Bancorp | May 21, 2026 | Advisory vote on the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amicus Therapeutics, Inc. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amkor Technology, Inc. | May 13, 2026 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Advisory vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amphastar Pharmaceuticals, Inc. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amphenol Corporation | May 21, 2026 | Election of Eight Directors: Robert A. Livingston | Director Elections | Board | AGAINST | 3 | |
| Amplitude, Inc. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Amylyx Pharmaceuticals, Inc. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Annexon, Inc. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Anterix Inc. | August 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Antero Midstream Corporation | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Antero Resources Corporation | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Aon Plc | June 26, 2026 | Authorize the Board to opt-out of statutory pre-emption rights under Irish Law. | Capital Structure | Board | AGAINST | 3 | |
| Aon Plc | June 26, 2026 | Election of Directors: Byron O. Spruell | Director Elections | Board | AGAINST | 3 | |
| Apogee Enterprises, Inc. | June 24, 2026 | ADVISORY VOTE TO APPROVE APOGEE'S EXECUTIVE COMPENSATION. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Apogee Therapeutics, Inc. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| AppFolio, Inc. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Appian Corporation | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Applied Digital Corporation | November 5, 2025 | Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Applied Industrial Technologies, Inc. | October 21, 2025 | Say on Pay - To approve, through a nonbinding advisory vote, the compensation of Applied's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Applied Optoelectronics, Inc. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| AptarGroup, Inc. | May 6, 2026 | Advisory vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Aramark | February 3, 2026 | To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arbor Realty Trust, Inc. | May 20, 2026 | Advisory vote to approve the compensation of Arbor Realty Trust, Inc.'s named executive officers as disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arbutus Biopharma Corporation | May 26, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| ArcBest Corporation | April 24, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Archer Aviation Inc. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Archrock, Inc. | April 30, 2026 | Advisory, non-binding vote to approve the compensation provided to our Named Executive Officers for 2025. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arcosa, Inc. | May 13, 2026 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arcus Biosciences, Inc. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arcutis Biotherapeutics, Inc. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Ardelyx, Inc. | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Argan, Inc. | June 10, 2026 | The non-binding advisory approval of our executive compensation (the "say-on-pay" vote). | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arista Networks, Inc. | May 29, 2026 | Election of Directors: Mark B. Templeton | Director Elections | Board | WITHHOLD | 3 | |
| Arlo Technologies, Inc. | June 18, 2026 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arrowhead Pharmaceuticals, Inc. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Artisan Partners Asset Management Inc. | June 3, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Artivion, Inc. | May 12, 2026 | To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Arvinas, Inc. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Asana, Inc. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay"). | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Asbury Automotive Group, Inc. | May 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Ashland Inc. | January 20, 2026 | Approval of the non-binding advisory resolution approving the compensation paid to Ashland's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| AstraZeneca PLC | April 9, 2026 | Authorise Issue of Equity | Capital Structure | Board | AGAINST | 3 | |
| AstraZeneca PLC | April 9, 2026 | Authorise Issue of Equity without Pre-emptive Rights | Capital Structure | Board | AGAINST | 3 | |
| AstraZeneca PLC | April 9, 2026 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Capital Structure | Board | AGAINST | 3 | |
| AstraZeneca PLC | April 9, 2026 | Re-elect Philip Broadley as Director | Director Elections | Board | AGAINST | 3 | |
| Astronics Corporation | May 28, 2026 | To approve the advisory resolution indicating the approval of the Compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Atkore Inc. | January 29, 2026 | The non-binding advisory vote approving executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Aurinia Pharmaceuticals Inc. | June 3, 2026 | Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Aurora Innovation, Inc. | May 21, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Autoliv, Inc. | May 7, 2026 | Advisory Vote on Autoliv, Inc.'s 2025 Executive Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avadel Pharmaceuticals plc | January 12, 2026 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avanos Medical, Inc. | April 21, 2026 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| AvePoint, Inc. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Aveanna Healthcare Holdings Inc. | May 29, 2026 | To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avidity Biosciences, Inc. | February 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avient Corporation | May 14, 2026 | Approval, on an advisory basis, of Named Executive Officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avis Budget Group, Inc. | May 20, 2026 | To vote, on an advisory basis, on the approval of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Avnet, Inc. | November 21, 2025 | Advisory vote on named executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Axalta Coating Systems Ltd. | June 3, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Axcelis Technologies, Inc. | May 5, 2026 | Say on Pay - An advisory vote on the approval of executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Axos Financial, Inc. | November 13, 2025 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Axsome Therapeutics, Inc. | June 5, 2026 | To approve, by non-binding advisory vote, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BGC Group, Inc. | November 12, 2025 | Approval, on an advisory basis, of executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BJ's Restaurants, Inc. | June 11, 2026 | Approval, on an advisory and non-binding basis, of the compensation of named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Badger Meter, Inc. | April 24, 2026 | ADVISORY VOTE TO APPROVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Banc of California, Inc. | May 6, 2026 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BancFirst Corporation | May 28, 2026 | Advisory vote to approve executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bank First Corporation | June 15, 2026 | To approve the compensation of the Company's named executive officers through an advisory vote. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bank of Hawaii Corporation | April 24, 2026 | Say on Pay - An advisory vote on executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BankUnited, Inc. | May 21, 2026 | Advisory vote to approve the compensation of the Company's named executive officers; and | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Banner Corporation | May 20, 2026 | Advisory (non-binding) approval of the compensation of our named executive officers as disclosed in this Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Barrett Business Services, Inc. | June 1, 2026 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Beacon Financial Corporation | May 13, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Beam Therapeutics Inc. | June 3, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Benchmark Electronics, Inc. | May 28, 2026 | To provide an advisory vote on the compensation of the Company's named executive officers; | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bentley Systems, Incorporated | May 21, 2026 | To approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BigBear.ai Holdings, Inc. | June 9, 2026 | To approve an advisory vote on our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bill Holdings, Inc. | December 11, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BioCryst Pharmaceuticals, Inc. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BioLife Solutions, Inc. | August 20, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BlackLine, Inc. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Blackbaud, Inc. | June 10, 2026 | ADVISORY VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Blackstone Mortgage Trust, Inc. | June 26, 2026 | Advisory Vote on Executive Compensation: To approve in a non-binding, advisory vote, the compensation paid to our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bloomin' Brands, Inc. | April 22, 2026 | Advisory Vote on Executive Compensation | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Blue Bird Corporation | March 11, 2026 | Advisory vote on executive compensation ("say-on-pay"). | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BorgWarner Inc. | April 29, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Boston Scientific Corporation | April 30, 2026 | Proposal to elect ten Directors: David C. Habiger | Director Elections | Board | AGAINST | 3 | |
| Box, Inc. | June 25, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Boyd Gaming Corporation | May 7, 2026 | Advisory vote on executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Brandywine Realty Trust | May 28, 2026 | Provide a non-binding, advisory vote on our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Braze, Inc. | June 30, 2026 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BridgeBio Pharma, Inc. | June 22, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Bright Horizons Family Solutions Inc. | June 3, 2026 | To approve, on an advisory basis, the 2025 compensation paid by the Company to its Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| BrightSpring Health Services, Inc. | May 21, 2026 | Advisory vote on executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Brighthouse Financial, Inc. | February 12, 2026 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Brighthouse Financial, Inc.'s named executive officers that is based on or otherwise relates to the Merger; and | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Brinker International, Inc. | November 20, 2025 | Advisory Vote to Approve Executive Compensation | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Brookdale Senior Living Inc. | July 11, 2025 | The Company's advisory proposal to approve the Company's named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 3 | |
| Brookdale Senior Living Inc. | June 22, 2026 | Advisory approval of named executive officer compensation | Say-on-Pay | Board (inferred) | AGAINST | 3 |
← Previous Page 5 of 24 Next →
← Back to UBS 2025-2026 overview
Built October 25, 2026 from SEC Form N-PX filings.